Too many companies are selling these prescription weight-loss drugs without adequate medical oversight, he said
NHS England commissioning guidance for specialist weight management services acknowledges that treatment plans should be individualised and that certain populations, including older adults with frailty or significant comorbidities, may require modified approaches
It has the same active ingredient in Victoza, liraglutide, a GLP-1 receptor agonist similar to semaglutide
This finding was later combined with research by Joel Habener and jointly published in JCI.11 The team of Jens Juul Holst at the University of Copenhagen in Denmark published a report in FEBS Letters, reaching the same conclusion in January 1987.23 In December 1987, Stephen Blooms team confirmed in a Lancet paper that GLP-1(7-36) is a human intestinal hormone that stimulates insulin production in the pancreas and lowers blood sugar.24 GLP-1, used for treating diabetes, is quickly broken down in the body, requiring high doses that can cause side effects like nausea
You may have a higher risk of eye-related side effects if you have: Existing eye conditions, especially diabetic retinopathy Diabetes-related eye disease High blood pressure High cholesterol Sleep apnea These conditions may also have an impact on vision, which makes it difficult to fully understand the impact of GLP-1 medications, says Dr
